192 related articles for article (PubMed ID: 38365970)
21. Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments.
Calabrò ML; Lazzari N; Rigotto G; Tonello M; Sommariva A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266161
[TBL] [Abstract][Full Text] [Related]
22. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
[TBL] [Abstract][Full Text] [Related]
23. Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.
Wu SM; Jan YJ; Tsai SC; Pan HC; Shen CC; Yang CN; Lee SH; Liu SH; Shen LW; Chiu CS; Arbiser JL; Meng M; Sheu ML
Cell Biol Toxicol; 2023 Oct; 39(5):1873-1896. PubMed ID: 34973135
[TBL] [Abstract][Full Text] [Related]
24. Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.
Li Q; Xiao X; Feng J; Yan R; Xi J
Front Endocrinol (Lausanne); 2023; 14():1196094. PubMed ID: 37404304
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy.
Liu QL; Luo M; Huang C; Chen HN; Zhou ZG
Front Oncol; 2021; 11():657546. PubMed ID: 33996581
[TBL] [Abstract][Full Text] [Related]
26. FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.
Kubo E; Shibata S; Shibata T; Kiyokawa E; Sasaki H; Singh DP
J Cell Mol Med; 2017 May; 21(5):916-928. PubMed ID: 27976512
[TBL] [Abstract][Full Text] [Related]
27. Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention.
Antony J; Thiery JP; Huang RY
Phys Biol; 2019 May; 16(4):041004. PubMed ID: 30939460
[TBL] [Abstract][Full Text] [Related]
28. The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells.
Ford CE; Jary E; Ma SS; Nixdorf S; Heinzelmann-Schwarz VA; Ward RL
PLoS One; 2013; 8(1):e54362. PubMed ID: 23326605
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-mesenchymal plasticity-engaging stemness in an interplay of phenotypes.
Chin VL; Lim CL
Stem Cell Investig; 2019; 6():25. PubMed ID: 31559312
[TBL] [Abstract][Full Text] [Related]
30. TGF-β isoforms induce EMT independent migration of ovarian cancer cells.
Gao J; Zhu Y; Nilsson M; Sundfeldt K
Cancer Cell Int; 2014; 14(1):72. PubMed ID: 25278811
[TBL] [Abstract][Full Text] [Related]
31. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
32. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Epithelial Splicing Regulatory Protein 1 in Metastatic Lesions of Serous Ovarian Carcinoma Correlates with Poor Patient Prognosis.
Lu X; Li R; Wang X; Guo Q; Wang L; Zhou X
Cancer Biother Radiopharm; 2022 Nov; 37(9):850-861. PubMed ID: 34495766
[No Abstract] [Full Text] [Related]
34. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
[TBL] [Abstract][Full Text] [Related]
35. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer.
Song IH; Kim KR; Lim S; Kim SH; Sung CO
Pathol Res Pract; 2018 Oct; 214(10):1564-1571. PubMed ID: 30082157
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
38. Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors.
Lanfredi GP; Thomé CH; Ferreira GA; Silvestrini VC; Masson AP; Vargas AP; Grassi ML; Poersch A; Candido Dos Reis FJ; Faça VM
Biochim Biophys Acta Proteins Proteom; 2021 Jun; 1869(6):140623. PubMed ID: 33607274
[TBL] [Abstract][Full Text] [Related]
39. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
Zhang Z; Xu Y
Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
[TBL] [Abstract][Full Text] [Related]
40. EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.
Chebouti I; Kasimir-Bauer S; Buderath P; Wimberger P; Hauch S; Kimmig R; Kuhlmann JD
Oncotarget; 2017 Jul; 8(30):48820-48831. PubMed ID: 28415744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]